Biblio

Found 360 results
Author Keyword [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
M. J. Piccart, Stuart, G. C. E., Cassidy, J., Bertelsen, K., Parmar, M. K. B., Eisenhauer, E., Kaye, S. B., Tropé, C. G., Swenerton, K. D., Harper, P., and Vermorken, J. B., Intergroup collaboration in ovarian cancer: a giant step forward., Ann Oncol, vol. 10 Suppl 1, pp. 83-6, 1999.
J. B. Vermorken, Intergroup collaboration in ovarian cancer: the Gynecologic Cancer Intergroup (GCIG), Int J Gynecol Cancer, vol. 11 Suppl 1, pp. 73-6, 2001.
J. B. Vermorken, Intergroup collaboration in ovarian cancer: the Gynecologic Cancer Intergroup (GCIG)., Int J Gynecol Cancer, vol. 11 Suppl 1, pp. 73-6, 2001.
A. Viswanathan, Creutzberg, C. L., Craighead, P., McCormack, M., Toita, T., Narayan, K., Reed, N. Simon, Long, H. J., Kim, H. - J., Marth, C., Lindegaard, J. C., Cerrotta, A., Small, W., and Trimble, E. L., International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG)., Int J Radiat Oncol Biol Phys, vol. 82, no. 1, pp. 250-5, 2012.
N. Colombo, Guthrie, D., Chiari, S., Parmar, M. K. B., Qian, W., Swart, A. Marie, Torri, V., Williams, C., Lissoni, A., Bonazzi, C., and Collaborators, I. Collaborat, International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer, J Natl Cancer Inst, vol. 95, pp. 125-32, 2003.
N. Colombo, Guthrie, D., Chiari, S., Parmar, M. K. B., Qian, W., Swart, A. Marie, Torri, V., Williams, C., Lissoni, A., and Bonazzi, C., International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer., J Natl Cancer Inst, vol. 95, no. 2, pp. 125-32, 2003.
J. B. Trimbos, Parmar, M. K. B., Vergote, I. B., Guthrie, D., Bolis, G., Colombo, N., Vermorken, J. B., Torri, V., Mangioni, C., Pecorelli, S., Lissoni, A., Swart, A. Marie, Neoplasm, I. Collaborat, Research, E. Organisati, and Neoplasm, Tof Cancer, International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma, J Natl Cancer Inst, vol. 95, pp. 105-12, 2003.
J. Martyn, Stonebraker, B., Carty, K., Bryce, J., and Bacon, M., International Harmonization of Ovarian Cancer Patient’s Tumor Assessments: A Gynecologic Cancer Intergroup (GCIG) Survey.. 2014.
E. L. Trimble, Ledermann, J. A., Law, K., Miyata, T., Imamura, C. K., Nam, B. - H., Kim, Y. H., Bang, Y. - J., Michaels, M., Ardron, D., Amano, S., Ando, Y., Tominaga, T., Kurokawa, K., and Takebe, N., International models of investigator-initiated trials: implications for Japan., Ann Oncol, vol. 23, no. 12, pp. 3151-5, 2012.
A. M. Poveda and Vermorken, J. B., The International Symposium on Advanced Ovarian Cancer. February 27, 2009, Spain., Int J Gynecol Cancer, vol. 19 Suppl 2, p. S1, 2009.
D. Armstrong, Bundy, B. N., Wenzel, L. B., Huang, H., Baergen, R., Lele, S., Copeland, L., Walker, J. L., Burger, R. A., and Group, G. Oncology, Intraperitoneal cisplatin and paclitaxel in ovarian cancer, N Engl J Med, vol. 354, pp. 34-43, 2006.
M. J. Piccart, Floquet, A., Scarfone, G., Willemse, P. H., Emerich, J., Vergote, I. B., Giurgea, L., Coens, C., Awada, A., and Vermorken, J. B., Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy, Int J Gynecol Cancer, vol. 13 Suppl 2, pp. 196-203, 2003.
L
C. Elie, Geay, J. - F., Morcos, M., Le Tourneau, A., Girre, V., Broet, P., Marmey, B., Chauvenet, L., Audouin, J., Pujade-Lauraine, E., Camilleri-Broet, S., and Group, G. I. N. E. C. O., Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GINECO group), Br J Cancer, vol. 91, pp. 470-5, 2004.
I. Cadron, Leunen, K., Amant, F., Van Gorp, T., Neven, P., and Vergote, I. B., The "Leuven" dose-dense paclitaxel/carboplatin regimen in patients with recurrent ovarian cancer, Gynecol Oncol, vol. 106, pp. 354-61, 2007.
E. Eisenhauer, Bacon, M., W, W., C, M. D., R, C., N, O., and Zee, B., Long term survivors from a European-Canadian Trial of paclitaxel in platinum-pretreated ovarian cancer. , Eur J Can , vol. 33, no. 8, 1997.
M. J. Piccart, Bertelsen, K., Stuart, G. C. E., Cassidy, J., Mangioni, C., Simonsen, E., James, K., Kaye, S. B., Vergote, I. B., Blom, R., Grimshaw, R., Atkinson, R. J., Swenerton, K. D., Tropé, C. G., Nardi, M., Kaern, J., Tumolo, S., Timmers, P., Roy, J. - A., Lhoas, F., Lidvall, B., Bacon, M., Birt, A., Andersen, J. E., Zee, B., Paul, J., Pecorelli, S., Baron, B., and McGuire, W. P., Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer, Int J Gynecol Cancer, vol. 13 Suppl 2, pp. 144-8, 2003.
M. J. Piccart, Bertelsen, K., Stuart, G. C. E., Cassidy, J., Mangioni, C., Simonsen, E., James, K., Kaye, S. B., Vergote, I. B., Blom, R., Grimshaw, R., Atkinson, R. J., Swenerton, K. D., Tropé, C. G., Nardi, M., Kaern, J., Tumolo, S., Timmers, P., Roy, J. - A., Lhoas, F., Lidvall, B., Bacon, M., Birt, A., Andersen, J. E., Zee, B., Paul, J., Pecorelli, S., Baron, B., and McGuire, W. P., Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer., Int J Gynecol Cancer, vol. 13 Suppl 2, pp. 144-8, 2003.
J. T. Thigpen, Bertelsen, K., Eisenhauer, E., Hacker, N. F., Lund, B., and Sessa, C., Long-term follow-up of patients with advanced ovarian carcinoma treated with chemotherapy., Ann Oncol, vol. 4 Suppl 4, pp. 35-40, 1993.
P. Grigsby, Winter, K., Komaki, R., Marcial, V., Eifel, P. J., Doncals, D., Stevens, R., Rotman, M., and Gaffney, D. K., Long-term follow-up of RTOG 88-05: twice-daily external irradiation with brachytherapy for carcinoma of the cervix, Int J Radiat Oncol Biol Phys, vol. 54, pp. 51-7, 2002.
N. Katsumata, Yasuda, M., Isonishi, S., Takahashi, F., Michimae, H., Kimura, E., Aoki, D., Jobo, T., Kodama, S., Terauchi, F., Sugiyama, T., Ochiai, K., and Group, J. Gynecologi, Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial, Lancet Oncol, vol. 14, pp. 1020-6, 2013.
M
M. C. Gainford, Tinker, A., Carter, J., Petru, E., Nicklin, J., Quinn, M., Hammond, I., Elit, L., Lenhard, M., and Friedlander, M. Leonard, Malignant transformation within ovarian dermoid cysts: an audit of treatment received and patient outcomes. an Australia New Zealand gynaecological oncology group (ANZGOG) and gynaecologic cancer intergroup (GCIG) study, Int J Gynecol Cancer, vol. 20, pp. 75-81, 2010.
C. M Gainford, Tinker, A., Carter, J., Petru, E., Nicklin, J., Quinn, M., Hammond, I., Elit, L., Lenhard, M., and Friedlander, M. Leonard, Malignant transformation within ovarian dermoid cysts: an audit of treatment received and patient outcomes. an Australia New Zealand gynaecological oncology group (ANZGOG) and gynaecologic cancer intergroup (GCIG) study., Int J Gynecol Cancer, vol. 20, no. 1, pp. 75-81, 2010.
H. C. Kitchener, Management of endometrial cancer., Eur J Surg Oncol, vol. 32, no. 8, pp. 838-43, 2006.
I. Ray-Coquard, Weber, B., Lotz, J. P., Tournigand, C., Provencal, J., Mayeur, D., Treilleux, I., Paraiso, D., Duvillard, P., Pujade-Lauraine, E., and Group, G. I. N. E. C. O., Management of rare ovarian cancers: the experience of the French website "Observatory for rare malignant tumours of the ovaries" by the GINECO group: interim analysis of the first 100 patients, Gynecol Oncol, vol. 119, pp. 53-9, 2010.
S. B. Kaye, Paul, J., Cassidy, J., Lewis, C. R., Duncan, I. D., Gordon, H. K., Kitchener, H. C., Cruickshank, D. J., Atkinson, R. J., Soukop, M., Rankin, E. M., Davis, J. A., Reed, N. Simon, Crawford, S. M., MacLean, A., Parkin, D., Sarkar, T. K., Kennedy, J., Symonds, R. P., and Group, S. Gynaecolog, Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group, J Clin Oncol, vol. 14, pp. 2113-9, 1996.

Pages